Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock.: Lessons learned from the IMPRESS in STEMI trial

Autor: Ouweneel, D.M., Engstrom, A.E., Sjauw, K.D., Hirsch, A., Hill, J.M., Gockel, B., Tuseth, V., van der Schaaf, R.J., Henriques, J.P.S.
Zdroj: In International Journal of Cardiology 1 January 2016 202:894-896
Databáze: ScienceDirect